Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls

The severe acute respiratory syndrome-corona virus type 2 (SARS-CoV-2) is the cause of human coronavirus disease 2019 (COVID-19). Since its identification in late 2019 SARS-CoV-2 has spread rapidly around the world creating a global pandemic. Although considered mainly a respiratory disease, COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Matschke, Jakob, Lahann, Henri, Krasemann, Susanne, Altmeppen, Hermann, Pfefferle, Susanne, Galliciotti, Giovanna, Fitzek, Antonia, Sperhake, Jan-Peter, Ondruschka, Benjamin, Busch, Miriam, Rotermund, Natalie, Schulz, Kristina, Lohr, Christian, Dottermusch, Matthias, Glatzel, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243237/
https://www.ncbi.nlm.nih.gov/pubmed/35785352
http://dx.doi.org/10.3389/fneur.2022.908081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243237/
https://www.ncbi.nlm.nih.gov/pubmed/35785352
http://dx.doi.org/10.3389/fneur.2022.908081

Ejemplares similares